Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

List of USP reference standards related to Prestwick3_000104

Client Email

Product

Prestwick3_000104
USP

PharmaCompass Sponsored Ads

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Prestwick3_000104

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

60 API Suppliers, 24 USDMF, 15 CEP/COS, 13 JDMF, 16 EU WC, 33 KDMF, 25 NDC API, 35 Listed Suppliers, $ API Reference Price

60 API Suppliers
24 USDMF
15 CEP/COS
13 JDMF
16 EU WC
33 KDMF
25 NDC API
35 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

16 API Suppliers

16 API Suppliers

FINISHED DOSAGE FORMULATIONS

215 FDF Dossiers, 143 FDA Orange Book, 24 Europe, 13 Canada, 2 Australia, 33 Listed Dossiers

215 FDF Dossiers
143 FDA Orange Book
24 Europe
13 Canada
2 Australia
33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Evonik, 7 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 6 DKSH, 2 Jai Radhe Sales, 2 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 30 BASF, 1 Bioplus Life Sciences, 2 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 10 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 28 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

97 Fillers, Diluents & Binders, 69 Coating Systems & Additives, 44 Direct Compression, 40 Controlled & Modified Release, 36 Thickeners and Stabilizers, 35 Solubilizers, 33 Disintegrants & Superdisintegrants, 28 Granulation, 28 Taste Masking, 25 Parenteral, 22 Topical, 19 Co-Processed Excipients, 18 Lubricants & Glidants, 17 Chewable & Orodispersible Aids, 15 Film Formers & Plasticizers, 10 Rheology Modifiers, 10 Emulsifying Agents, 9 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 4 Coloring Agents

97 Fillers, Diluents & Binders
69 Coating Systems & Additives
44 Direct Compression
40 Controlled & Modified Release
36 Thickeners and Stabilizers
35 Solubilizers
33 Disintegrants & Superdisintegrants
28 Granulation
28 Taste Masking
25 Parenteral
22 Topical
19 Co-Processed Excipients
18 Lubricants & Glidants
17 Chewable & Orodispersible Aids
15 Film Formers & Plasticizers
10 Rheology Modifiers
10 Emulsifying Agents
9 API Stability Enhancers
5 Empty Capsules
5 Surfactant & Foaming Agents
4 Vegetarian Capsules
4 Coloring Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 61 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
61 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 31 Finished Drug Prices, 3 Annual Reports

4 US Medicaid Prescriptions
31 Finished Drug Prices
3 Annual Reports

MARKET PLACE

40 APIs, 42 FDF Dossiers

40 APIs
42 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 4 Health Canada Patents

5 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 6 USP, 16 Others

3 EDQM
6 USP
16 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 101 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

6 All

01 11269200

02 11269221

03 11269232

04 11269243

05 11269254

06 11269265

filter Description Reset all filters

6 All

01 1Famotidine (125 mg)

02 1Famotidine Related Compound B (25 mg) (3,5-bis[2-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphany]ethyl]-4H-1,2,4,6-thiatriazine1,1-dioxide)

03 1Famotidine Related Compound C (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]-N-sulfamoylpropanamide hydrochloride)

04 1Famotidine Related Compound D (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanamide)

05 1Famotidine Related Compound E (25 mg) (2,2'-[4,4'-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguanidine)

06 1Famotidine Related Compound F (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid)

filter CAS Number Reset all filters

6 All

01 1107880-74-0

02 1129083-44-9

03 176824-16-3

04 176824-17-4

05 176824-35-6

06 189268-62-2

BioAnalytical Methods
EDQM
USP Standards
Others

Product Main Page

01

USP

Formnext Forum

Not Confirmed

USP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Famotidine Related Compound F (25 mg) (3-[[2-...

CAS Number : 107880-74-0

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1269265

Current Lot : F1K060

Previous Lot : F0K060 (31-MAR-2018)

NDC Code :

Product Web Link

Digital Content

02

USP

Formnext Forum

Not Confirmed

USP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Famotidine Related Compound E (25 mg) (2,2'-[...

CAS Number : 129083-44-9

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1269254

Current Lot : F1K059

Previous Lot : F0K059 (31-MAR-2018)

NDC Code :

Product Web Link

Digital Content

03

USP

Formnext Forum

Not Confirmed

USP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Famotidine Related Compound D (25 mg) (3-[[2-...

CAS Number : 76824-16-3

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1269243

Current Lot : F1K058

Previous Lot : F0K058 (30-NOV-2016)

NDC Code :

Product Web Link

Digital Content

04

USP

Formnext Forum

Not Confirmed

USP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Famotidine Related Compound C (25 mg) (3-[[2-...

CAS Number : 76824-17-4

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1269232

Current Lot : F1K160

Previous Lot : F0K160 (31-MAR-2018)

NDC Code :

Product Web Link

Digital Content

05

USP

Formnext Forum

Not Confirmed

USP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Famotidine Related Compound B (25 mg) (3,5-bi...

CAS Number : 89268-62-2

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1269221

Current Lot : R05620

Previous Lot : F0G182 (31-JAN-2018)

NDC Code :

Product Web Link

Digital Content

06

USP

Formnext Forum

Not Confirmed

USP

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Famotidine (125 mg)

CAS Number : 76824-35-6

Quantity Per Vial :

Price ($) : 185

Catalog Number : 1269200

Current Lot : R048S0

Previous Lot : I0E063 (31-JUL-2017)

NDC Code :

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?